Accelerating Early-Stage Drug Discovery: How Novalix Integrates CDD Vault and StarDrop for Smarter R&D
As the drug discovery community navigates the transition from manual, paper-based workflows to digitally enhanced environments, contract research organizations (CROs) like Novalix are leading the charge in streamlining analytical data management.
Drawing on insights from its multi-site operations across France and Tunisia, this free report explores how the integration of centralized data hubs and advanced molecular design platforms can overcome the traditional bottlenecks of early-stage research.
Discover:
Why centralizing data benefits R&D organizations
With advantages ranging from time saved refining, interrogating and reporting data...
...to collaborative opportunities across geographies - all supporting effective, efficient early-stage pharmaceutical research
- The Power of Seamless Integration
With API integration, the benefits of CDD Vault - such as scalable, modular architecture and a user-friendly interface - are augmented by Optibrium's StarDrop™, providing an intuitive environment for molecular design and data analysis in hit-to-lead discovery and lead optimization workflows.
- Real-world examples
Direct testimonals from industry leaders such as Laurent Saniere, PhD, Novalix Senior VP and Head of Drug Discovery - along with detailed accounts from senior scientists across the organisation.
Unlock the benefits of effective, integrated and centralised data management today.
Download the full report below to find out more.
